TerminatedPHASE2, PHASE3NCT00989820
Efficacy of Hyperbaric Oxygen Therapy in the Treatment of Osteoradionecrosis
Studying Osteoradionecrosis of the mandible
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radboud University Medical Center
- Principal Investigator
- Francois Dieleman, MD DMDRadboud University Medical Center
- Intervention
- hyperbaric oxygen(drug)
- Enrollment
- 20 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2020
Study locations (8)
- NKI/AvL, Amsterdam, Netherlands
- VU University Medical centre, Amsterdam, Netherlands
- University Medical Center Groningen, Groningen, Netherlands
- Leiden University Medical Center, Leiden, Netherlands
- Maastricht Universitary Medical Centre, Maastricht, Netherlands
- Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
- Erasmus University Medical Center, Rotterdam, Netherlands
- University Medical Center Utrecht, Utrecht, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00989820 on ClinicalTrials.govOther trials for Osteoradionecrosis of the mandible
Additional recruiting or active studies for the same condition.